
|Articles|September 5, 2014
The Transatlantic Trade and Investment Partnership: From Hot TTIP to Oblivion?
Author(s)Reflector
Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean.
Advertisement
Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean. TTIP, the Transatlantic Trade and Investment Partnership, was the hot tip for a 2014 success story. But as summer slides away and autumn beckons, the latest read-out of progress suggests that rather than remaining a hot tip, TTIP now risks being tipped into oblivion.
For the rest of this article,
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
The New Healthy Aging Imperative and What It Means for Pharma
3
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
4
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
5




